Mode
Text Size
Log in / Sign up
Phase 2 Completed N=63 Randomized Double-blind Treatment

Tailored Tobacco Quitline for Rural Veterans

Cigarette Smoking
Source: ClinicalTrials.gov NCT01592695 ↗
Enrolled (actual)
63
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcomePrimary: Treatment Satisfaction — 17; 6; 16; 7 Participants

Summary

The proposed work is designed to help increase access to tobacco cessation services among rural veterans and to develop more effective treatment services that better address comorbid issues commonly experienced by rural smokers. The objectives are: 1. Study the feasibility of an individually-tailored telephone intervention for rural smokers. 2. Examine the impact of the intervention on tobacco use outcomes. 3. Evaluate the effect of the intervention on issues commonly experienced by rural smokers including depressive symptoms, alcohol use, and weight gain.

Outcome Measures

OutcomeResultp-value
PRIMARY
Treatment Satisfaction
17; 6; 16; 7; 16; 9
SECONDARY
Number of Participants Abstinent From Tobacco Use
9; 9
SECONDARY
Alcohol Use
9.5; 2.8
SECONDARY
Depressive Symptoms
7.0; 3.9
SECONDARY
Body Weight
214.0; 228.2
SECONDARY
Enrollment Rate
31; 32
SECONDARY
Retention
16
SECONDARY
Treatment Attendance
4.0

Eligibility Criteria

Inclusion Criteria

  • Being a veteran
  • 18 + years of age
  • Smoke cigarettes on at least a daily basis
  • Receive primary care from the Iowa City VAMC or Coralville Clinic
  • Live in a non-metropolitan area (based on RUCA codes)
  • Be willing to make a quit attempt in the next 30 days
  • Be capable of providing informed consent
  • Have access to a telephone (land line or cell phone)
  • Have a stable residence

Exclusion Criteria

  • Planning to move within the next 12 months
  • Presence of a terminal illness
  • Pregnancy
  • Unstable psychiatric disorder (e.g., acute psychosis)
  • Currently pregnant
  • Incarcerated
  • Institutionalized
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01592695). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search